In this issue of JAMA Psychiatry, Jones and colleagues present 2 principal insights. First, during the COVID-19 pandemic, emergency authorities implemented to expand telehealth access were widely used among Medicare beneficiaries who were initiating opioid use disorder (OUD) treatment episodes. Second, beneficiaries who received OUD-related telehealth services displayed improved treatment retention and lower odds of medically treated overdoses. While more evidence-based strategies for OUD treatment engagement are necessary, these findings support permanent adoption of expanded telehealth access and prescribing flexibilities.